Abstract
Molecular diagnostics are validated clinical tools available today for most all clinicians. Given the expanded microbial census they elucidate with DNA-level certainty, a new microbial reality has emerged making interpretation pivotal to advancing outcomes. Regarding chronic infection, there is little consensus for interpretation, even from traditional culture. To advance outcomes, the authors propose an escalating chronic infection protocol leveraging multiple concurrent strategies. A pivotal aspect, directing multiple legs of the protocol, is the diagnostic objectivity and accuracy of molecular diagnostics.
Using the combination of polymerase chain reaction and pyrosequencing (PCR:PSEQ) applied to chronic wounds, clinical outcomes are highlighted in a chronic infection example. Absolute healing rates for microbial DNA guided topical treatments including antibiotics and antibiofilm agents were approximately twice that of culture directed therapy (p<0.001). Further, median days to closure were 177 days for culture directed therapy versus 28days for microbial DNA guided topical treatments (p<0.001).
Absent of cultivation biases and limitations, PCR:PSEQ accurately identifies all known bacteria, yeast, and fungi. While the utility of PCR:PSEQ has become relatively established for chronic wounds, the use of these methods for any chronic infection is warranted whenever the comprehensive microbial contribution is clinically relevant to interventional strategy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Chakraborti C, Le C, Yanofsky A (2010) Sensitivity of superficial cultures in lower extremity wounds. J Hosp Med 5(7):415–420
del Pozo JL, Patel R (2007) The challenge of treating biofilm-associated bacterial infections. Clin Pharmacol Ther 82:204–209
Dowd SE, Wolcott R (2010) Molecular diagnosis: a new era in wound care. Today’s Wound Clinic 2:24–27
Dowd SE, Wolcott RD, Sun Y et al (2008a) Polymicrobial nature of chronic diabetic foot ulcer biofilm infections determined using bacterial tag encoded FLX amplicon pyrosequencing (bTEFAP). PLoS One 3:e3326
Dowd SE, Sun Y, Secor PR et al (2008b) Survey of bacterial diversity in chronic wounds using Pyrosequencing, DGGE, and full ribosome shotgun sequencing. BMC Microbiol 8:43
Dowd SE, Wolcott RD, Kennedy J, Jones C, Cox SB (2011) Molecular diagnostics and personalised medicine in wound care: assessment of outcomes. J Wound Care 20:232–239
El-Azizi M, Rao S, Kanchanapoom T, Khardori M (2005) In vitro activity of vancomycin, quinupristin/dalfopristin, and linezolid against intact and disrupted biofilms of staphylococci. Ann Clin Microbiol Antimicrob 4:2
Gardner SE, Frantz RA, Doebbeling BN (2001) The validity of the clinical signs and symptoms used to identify localized chronic wound infection. Wound Repair Regen 9:178–186
Kennedy JP (2011) Molecular enabled personalized medicine for chronic infection. Chronic orthopaedic infection conference, Center for Genomic Sciences, Allegheny-Singer Research Institute, Pittsburgh, PA, May 2011
Lazăr V, Chifiriuc MC (2010) Medical significance and new therapeutically strategies for biofilm associated infections. Roum Arch Microbiol Immunol 69:125–138
Rennie RP, Jones RN, Mutnick AH (2003) Occurrence and antimicrobial susceptibility patterns of pathogens isolated from skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 2000). Diagn Microbiol Infect Dis 45:287–293
Sun Y, Smith E, Wolcott R, Dowd SE (2009) Propagation of anaerobic bacteria within an aerobic multispecies chronic wound biofilm model. J Wound Care 18:426–431
Wolcott RD, Rhoads DD (2008) A study of biofilm-based wound management in subjects with critical limb ischaemia. J Wound Care 17:145–155
Wolcott RD, Gontcharova V, Sun Y, Dowd SE (2009) Evaluation of the bacterial diversity among and within individual venous leg ulcers using bacterial tag-encoded FLX and titanium amplicon pyrosequencing and metagenomic approaches. BMC Microbiol 9:226
Wolcott RD, Cox SB, Dowd SE (2010a) Healing and healing rates of chronic wounds in the age of molecular pathogen diagnostics. J Wound Care 19:272–281
Wolcott RD, Rumbaugh KP, James G, Schultz G, Phillips P, Yang Q, Watters C, Stewart PS, Dowd SE (2010b) Biofilm maturity studies indicate sharp debridement opens a time-dependent therapeutic window. J Wound Care 19:320–328
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Kennedy, J.P., Jones, C.E. (2012). Improved Outcomes Via Integrated Molecular Diagnostics and Biofilm Targeted Therapeutics. In: Ehrlich, G., DeMeo, P., Costerton, J., Winkler, H. (eds) Culture Negative Orthopedic Biofilm Infections. Springer Series on Biofilms, vol 7. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-29554-6_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-29554-6_4
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-29553-9
Online ISBN: 978-3-642-29554-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)